EDGAR Filing Documents for 0001193125-18-013336

Form 8-K - Current report:

SEC Accession No. 0001193125-18-013336

Filing Date

2018-01-18

Accepted

2018-01-18 16:15:32

Documents

Period of Report

2018-01-16

Items

Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d527055d8k.htm	8-K	14774
2	EX-99.1	d527055dex991.htm	EX-99.1	6802
3	GRAPHIC	g527055page5.jpg	GRAPHIC	4661
	Complete submission text file	0001193125-18-013336.txt		29326

Mailing Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306

Business Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306 650-279-9845

Eiger BioPharmaceuticals, Inc. (Filer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36183 | Film No.: 18534132
SIC: 2836 Biological Products, (No Diagnostic Substances)